Relation of Direct Assessment of Cardiac Autonomic Function With Metaiodobenzylguanidine Imaging to Heart Rate Variability in Diabetes Mellitus
Section snippets
Acknowledgements
We acknowledge the research assistance of Heather Hink, RN, the expert technical support of Lois Adams, BSc, Terry Hsia, RT, BSc, and the secretarial assistance of Tami Gallivan.
This study was supported in part by the Canadian Diabetes Association, Toronto, Ontario, Canada.
References (20)
- et al.
Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia
J Am Coll Cardiol
(1995) - et al.
Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure
J Electrocardiol
(1992) - et al.
Parasympathetic activity is a major modulator of the circadian variability of heart rate in healthy subjects and in patients with coronary artery disease or diabetes mellitus
Am Heart J
(1993) - et al.
Validity of mathematical methods of quantitating fetal heart rate variability
Am J Obstet Gynecol
(1985) - et al.
Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications
Ann Intern Med
(1980) - et al.
Defective innervation of heart in diabetic autonomic neuropathy
Br Med J
(1975) Cardiorespiratory arrest in diabetic autonomic neuropathy
Lancet
(1978)- et al.
Assessment of methods for estimating nervous control of the heart in patients with diabetes mellitus
Diabetes
(1978) - et al.
Noninvasive detection of cardiac sympathetic nervious dysfunction in diabetic patients using [123] metaiodobenzylguanidine
Diabetes
(1992) - et al.
Myocardial m-[123]Iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM.Comparison with cardiovascular reflex tests and relationship to left ventricular function
Diabetes
(1994)
Cited by (14)
Microneurographic evaluation of sympathetic activity in small fiber neuropathy
2011, Clinical NeurophysiologyCitation Excerpt :To obtain the highest sensitivity and specificity it has been suggested that a reliable approach to APN diagnosis include a combination of various autonomic tests in the composite autonomic scoring scale (CASS), which includes QSART, orthostatic blood pressure, heart rate response to tilt, heart rate response to deep breathing, the Valsalva ratio, and beat-to-beat blood pressure measurements during phases II and IV of the Valsalva maneuver, tilt, and deep breathing (Low 1993, 2003b). Furthermore, quantitative scintigraphic assessment of sympathetic innervation of the human heart is possible with positron emission tomography (PET) and either [123I]meta-iodobenzylguanidine (MIBG) or [11C]-meta-hydroxy-ephedrine ([11C]HED) (Goldstein et al., 1990; Freeman et al., 1997; Raffel and Wieland, 2001). These functional imaging techniques are very promising providing direct, non-invasive and quantitative information of sympathetic cardiac innervation.
Pupillography refines the diagnosis of diabetic autonomic neuropathy
2004, Journal of the Neurological SciencesMIBG imaging
2002, Journal of Nuclear CardiologyDiabetic Cardiac Autonomic Neuropathy
2023, The Diabetes Textbook: Clinical Principles, Patient Management and Public Health Issues, Second EditionAutonomic nervous system activity in primary Raynaud's phenomenon: Heart rate variability, plasma catecholamines and [<sup>123</sup>I]MIBG heart scintigraphy
2022, Clinical Physiology and Functional ImagingPeripheral autonomic neuropathy: Diagnostic contribution of skin biopsy
2012, Journal of Neuropathology and Experimental Neurology